November 18, 2026 Medical Oddities: A spoonful of surgical trouble A spoon gets stuck, fiber fights plastics, smells shift balance, and tea teases bone benefits this week. MDSpire News
November 16, 2026 MS gray matter loss reveals network-based mechanisms Connected cortical regions exhibited similar patterns of tissue loss, while network measures helped explain subsequent atrophy progression. MDSpire News
November 03, 2026 BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial The company also reported early efficacy and safety data from the Phase I Breakfree-2 study The Medicine Maker
September 24, 2026 DPP-4 inhibitors may have specific autoimmune risks Associations with dermatomyositis, bullous pemphigoid, psoriasis, and autoimmune thyroiditis differed across commonly used diabetes drug classes. MDSpire News
September 02, 2026 What heat brings to acute care Researchers screened more than 1,800 diagnosis categories across nearly 917,000 acute-care encounters in Chicago. MDSpire News
August 31, 2026 Emergency diagnosis may flag poor outcomes beyond cancer Across 13 noncancer conditions, emergency diagnosis was common and associated with higher 1-year mortality. MDSpire News
August 20, 2026 Musings from The Power List: Daniel Vitt From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development The Medicine Maker
July 13, 2026 In Vivo CAR T: A New Route to Treating Autoimmune Disease How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments The Medicine Maker
July 09, 2026 Top 10 Evidence-Based Essentials in Neurology A structured framework of guidelines, trials, therapies, and tools used in clinical practice. MDSpire News
July 07, 2026 Head-to-Head Trial in Relapsing MS The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity. MDSpire News